Overview

The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors

Status:
Recruiting
Trial end date:
2023-08-30
Target enrollment:
Participant gender:
Summary
A Phase 1 Dose Escalation and Expansion Study of IMP7068 Monotherapy in Advanced Solid Tumors
Phase:
Phase 1
Details
Lead Sponsor:
Impact Therapeutics, Inc.
Collaborator:
Covance